Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
73
NCT04289103
Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 31, 2021
Completion: Jun 30, 2024
NCT05453279
A Dose Escalation Phase 1 Study Evaluating the Safety and Pharmacokinetics of an Inhaled COVID-19 Inhibitor Delcetravir in Healthy Subjects
Phase: Phase 1
Start: Sep 1, 2022
Completion: Jan 1, 2023